1. Home
  2. |Insights
  3. |Government Contracts M&A Series – 2021 Market Overview and Key Areas of Focus in 2022

Government Contracts M&A Series – 2021 Market Overview and Key Areas of Focus in 2022

Webinar | 02.08.22, 7:00 AM EST - 8:00 AM EST

Register

Join us for the first webinar in a new series aimed at exploring best practices in mergers & acquisitions involving government contractors.  We will review the state of the market in 2021 and discuss key areas of focus carrying into 2022, as well as best practices for transaction planning in the current market.  Our panel will also include insights from our experienced partners at Avascent and Harris Williams.  Topics will include:

  • Recent trends across private equity and venture capital investments in the US federal government sector
  • Trends in acquisition strategies for government customers (e.g. OTAs, SBIRs)
  • Outlook for government applications and procurements of emerging and dual-use technologies (e.g. artificial intelligence, cloud computing) 
  • Considerations for foreign buyers looking to enter into or expand in the US market
  • Small business status impacts
  • State and local contractor considerations
  • Focus areas for M&A due diligence, including ESG, cybersecurity, and other considerations

Guest Speakers: 

  • Tim Garnett - Avascent, Founder/Managing Director – Head of M&A and Transaction Support
  • Chris Rogers - Harris Williams, Managing Director/Group Head – Aerospace, Defense & Government Services (ADG) Group

For more information, please visit these areas: Government Contracts

Contact

Participants

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.

View All Insights